Sign up to save your podcasts
Or
Share Cordis acquires MedAlliance for more than $1B, SmileDirectClub files Chapter 11
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cordis acquires MedAlliance for more than $1B, SmileDirectClub files Chapter 11
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 3, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
The FDA this week approved Enable Injections' wearable injector. Fast Five hosts Sean Whooley and Danielle Kirsh share what the wearable injector does and what executives are saying about the approval.
Boston Scientific announced the launch of its next-generation insertable cardiac monitor. Find out what this next-gen system does, who some of the key players in the ICM space are and more in today's episode.
Pulse Biosciences and CardioNXT are partnering up to initiate a pulsed-field ablation trial. Whooley details what the goal of the collaboration is and how the two companies plan to achieve it.
SmileDirectClub has filed for Chapter 11 bankruptcy protection and announced plans to recapitalize. Hear more about the announcement and what the recapitalization process will entail.
Cordis has acquired drug-eluting balloon maker MedAlliance for up to $1.135 billion. The Fast Five hosts discuss the financial details of the deal and some of the comments that executives had about the deal.
View all episodes
By MassDeviceWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 3, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
The FDA this week approved Enable Injections' wearable injector. Fast Five hosts Sean Whooley and Danielle Kirsh share what the wearable injector does and what executives are saying about the approval.
Boston Scientific announced the launch of its next-generation insertable cardiac monitor. Find out what this next-gen system does, who some of the key players in the ICM space are and more in today's episode.
Pulse Biosciences and CardioNXT are partnering up to initiate a pulsed-field ablation trial. Whooley details what the goal of the collaboration is and how the two companies plan to achieve it.
SmileDirectClub has filed for Chapter 11 bankruptcy protection and announced plans to recapitalize. Hear more about the announcement and what the recapitalization process will entail.
Cordis has acquired drug-eluting balloon maker MedAlliance for up to $1.135 billion. The Fast Five hosts discuss the financial details of the deal and some of the comments that executives had about the deal.